Amgen acquired worldwide rights to psoriasis drug Otezla (apremilast) For $13.4 Billion
On Aug. 26, 2019, Amgen acquired worldwide rights to Otezlaﾮ (apremilast), the only oral, non-biologic treatment for psoriasis…
-
-
City of Port St Lucie Council voted to ﾠLeaseﾠ former VGTI Florida facility to the ﾠCleveland Clinic for $1 per year
On Aug. 26, 2019 , the City of Port St. Lucie Council voted 5 to 0 to ﾠleaseﾠ…
-
Chinook Therapeutics Raises $65 Million Series A Financing to Advance Precision Medicines for Kidney Diseases
On Aug. 22, 2019, Chinook Therapeutics announced a $65 million Series A financing to discover and develop precision…
-
Siteman Cancer Center received $15 million grant to support personalized leukemia therapies
On Aug. 21, 2019, the Siteman Cancer Center announced it was awarded a $15 million grant to better…
-
Karmanos Cancer Institute became the first in Michigan to offer patients the Leksell Gamma Knife Icon stereotactic radiosurgery system
On Aug. 19, 2019, the Barbara Ann Karmanos Cancer Institute announced it became the first cancer center in…
-
Biotechnology | Disease | Non-Profit Research | Oncology | Pharmaceutical | Rare Disease | Therapeutics
CPRIT granted $18.7 million New Company Product Development award to Salarius Pharmaceuticals
On Aug. 15, 2019, the Cancer Prevention and Research Institute of Texas (CPRIT) announced that it was awarded…
-
Masonic Cancer Center researchers awarded $8.5 million dollar grant to research metastatic breast cancer
On Aug. 15, 2019, Masonic Cancer Center researchers Reuben Harris, PhD and Douglas Yee, MD announced that they…
-
Siteman Cancer Center awarded $7.8 million to expand clinical trials access
On Aug. 1, 2019 the Siteman Cancer Center announced it was awarded a six-year, $7.8 million grant from…
-
Vanderbilt University Medical Center Professor David Cortez, PhD and colleagues revealed a new DNA repair pathway
On Jul. 25, 2019, Vanderbilt University Medical Center Professor David Cortez, PhD and colleagues revealed a new DNA…
-
CDC published ACIP recommendations on use of Japanese encephalitis vaccine
On Jul. 19, 2019, the Centers for Disease Control and Prevention (CDC) published recommendations from the Advisory Committee…
-
Masonic Cancer Center member Ingunn Stromnes, PhD awarded with PanCAN Grant
On Jul. 9, 2019, the Masonic Cancer Center announced that researcher Ingunn Stromnes, PhD was awarded with a…
-
Evotec completed acquisition of Just Biotherapeutics
On Jul. 3, 2019, Evotec announced the strategic transaction to acquire Just Biotherapeutics, signed May 20, 2019, had…
-
DARPA funded a $21.9 gene modulation research initiative at Georgia Tech, targeting influenza pandemics
In Jun. 2019, Defense Advanced Research Projects Agency (DARPA) announced it had funded a $21.9 gene modulation research…
-
Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019 signed into law
On Jun. 24, 2019, the Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019 (S.1379) passed by…
-
CanSinoBIO received approval for Its 13-valent penumococcal conjugate vaccine to start clinical trials
On Jun. 20, 2019, CanSino Biologics announced that it had received the National Medical Products Administration’s (NMPA) permission…
-
Columbia Sportswear’s Tim and Mary Boyle announced a $10 million gift to OHSU Knight Cancer Institute
On Jun. 18, 2019, Columbia Sportswear President and CEO Tim Boyle and his wife, Mary, announced a donation…
-
New CRISPR Lab for Genomic Research at UCSF and UC Berkeley in collaboratation with GlaxoSmithKline
On Jun. 13, 2019, the University of California, San Francisco and University of California, Berkeley collaborated with GlaxoSmithKline…
-
Groundbreaking DNA study launched to discover new connections between genetics & diseases
On Jun. 12, 2019, Intermountain Healthcare and deCODE genetics announced a major global collaboration and study focused on…
-
Vaccitech universal flu vaccine passed Phase 2b clinical development milestones
On Jun. 5, 2019, Vaccitech announced that it has administered its pandemic universal influenza A vaccine MVA-NP+M1 (VTP-100)…
-
The Cancer Prevention and Research Institute of Texas awarded a relocation grant to Hummingbird Bioscience
On Jun. 4, 2019, the Cancer Prevention and Research Institute of Texas (CPRIT) awarded a $13 million relocation…
-
Penn received a $12 million grant to study the connection between cellular therapies and new methods of radiation therapy
On Jun. 3, 2019, the University of Pennsylvania (Penn) announced it had received a $12 million grant from…
-
FUJIFILM opened Life Science Strategic Business Office in Cambridge, Massachusetts
On May 30, 2019, FUJIFILM opened a Life Science Strategic Business Office in Cambridge, Massachusetts to create a…
-
The Richard N Merkin Institute for Translational Research was founded at CalTech
On May 30, 2019, The Richard N. Merkin Institute for Translational Research was founded at CalTech. Merkin, who…
-
Amgen announced the launch of Amgen Community Oncology Research Collaborators
On May 28, 2019, Amgen, along with leading community oncology networks, announced the launch of Amgen Community Oncology…
-
At $2M, priciest ever medicine treats fatal genetic disease
On May 24, 2019, U.S. regulators have approved the most expensive medicine ever, for a rare disorder that destroys…
-
UGA researchers discovered a vaccine for Crimean-Congo Hemorrhagic Fever (CCHF) virus
On Apr. 25, 2019, researchers at the University of Georgia announced they had successfully discovered a single-dose vaccine…
-
Massachusetts General Hospital received $200 million to advance research into complex diseases
On Apr. 25, 2019, Massachusetts General Hospital (MGH) announced it had received the largest gift in the hospital’s…
-
Amgen announced FDA approval of EVENITY for the treatment of osteoporosis
On Apr. 9 2019, Amgen announced U.S. Food and Drug Administration (FDA) approval of EVENITY (romosozumab-aqqg) for the…
-
Chembio Diagnostics received approval of Zika, Dengue and Chikungunya point-of-care multiplex test by Brazil’s Health Regulatory Agency
On Apr. 9, 2019, Chembio Diagnostics announced the approval of its DPP Zika/Dengue/Chikungunya System by Agencia Nacional de…
-
The only FDA approved IV antimalarial in the US, IV quinidine, was discontinued
In Mar. 29, 2019, the Centers for Disease Control and Prevention (CDC) issued new guidance to clinicians for…
